Michael Powell, Director, 10% Owner at Trius Therapeutics Inc (TSRX), bought 3,615,572 shares at $5.00 ($8.1M) on 2010-08-06, disclosed to the SEC on 2010-08-10.
Open-market purchase of $8.1M TSRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,892,177 | $0 | 0.0% |
| 2 | $4.38 | 893,395 | $3.9M | 48.5% |
| 3 | $5.00 | 830,000 | $4.2M | 51.5% |
| Total | $2.23 avg | 3,615,572 | $8.1M | 100% |
| Filing → |
| OCRX | SELL | 2016-12-30 | $15K | — | Filing → |
| MIRN | BUY | 2015-10-06 | $6.0M | — | Filing → |
| AERI | SELL | 2014-07-11 | $24.2M | — | Filing → |